Polyomavirus middle tumor antigen (MT) transform a large number of cell types by binding to and modulating the activities of cellular proteins. Previous genetic ansis defined in MT an independent motif, NPTY (Asn-Pro- Because expression of pp60v-ff induces tyrosine phosphorylation of SHC and subsequent activation of Ras, activated pp60c-src in complex with MT might do the same. A potential candidate for SHC had been reported in MT immunoprecipitates, a 51-kDa protein of unknown identity (34) . Because phosphorylation at Tyr-250 was implicated in transformation, it was tempting to hypothesize that SHC might bind via its SH2 to this site. Our data confirm that SHC does bind to MT in an NPTY-dependent manner. 
Middle tumor antigen (MT), the principal transforming protein of polyomavirus, has no known intrinsic enzymatic activity. It transforms by associating with and modulating the activities of cellular proteins involved in control of cell proliferation. Among the cellular targets MT binds are the Src family tyrosine kinases pp6OC-src (1) , pp62c-Yes (2), and pp59c-fyn (3) . Genetic analysis demonstrated that activation of these kinases is necessary for MT transformation (for review, see refs. 4 hnd 5). However, two mutants, d123 and d11015, activated tyrosine kinases (6, 7) and yet failed to transform, indicating that activation is not sufficient. One explanation that applies to d123 was found in the phosphorylation of MT. In complexes with tyrosine kinases, MT itself became phosphorylated at Tyr-315 and, to a lesser extent, at Tyr-250 and Tyr-322 (8) (9) (10) . MTs with mutations at position 315, d123 (11) , and Py1178T (12) , or position 250, pT250 (13) , were transformation defective. Subsequent research identified a phosphatidylinositol 3-kinase (PI 3-kinase) (14, 15) associated with MT via Tyr-315 and neighboring amino acids (16) (17) (18) . Immunoprecipitates of d123 or Py1178T MT were deficient in this activity, providing a biochemical explanation for their transformation defect (15, 19, 20) .
However, neither association with tyrosine kinase nor PI 3-kinase could explain a transformation-defective MT mutant carrying Pro-248 --Leu (21) . Mutation ofamino acids around position 248 generated mutants competent to associate with pp60C-src and PI 3-kinase and yet transformation-defective.
This set of mutants defined a motif in MT, Asn-Pro-Thr-Tyr (or NPTY). Mutation ofany ofthese four amino acids yielded a transformation-defective phenotype (22, 23) . Significantly, mutations in NPTY could be rescued by inserting a second NPTY motif at another position in MT. Strikingly, a variant of MT containing two wild-type NPTY motifs yielded foci 5-to 10-fold larger than wild type (23) . The NPTY sequence in MT is a member of the more general motif NPXY, first described as important for low-density lipoprotein receptor internalization (24) . Although mutation of the NPXY motifof MT might affect its subcellular localization, such a change was not detected (23) .
A more general view of cell-growth regulation suggested an explanation for such mutants. Microinjection of anti-Ras antibody blocked growth response to serum (25) and a dominant negative Ras mutant prevented growth of pp60v-src transformants (26) . Ras lies downstream of MT (27, 28) (29, 30) . SHC protein consists of three overlapping polypeptides of -46, 52, and 66 kDa (29, 31) . It acts as an intermediate in activation of the GRB2/SOS complex in both epidermal growth factor (EGF)-stimulated and pp60vsrc-transformed cells (30, 32) . In EGF-stimulated cells, SHC associates with the activated EGF receptor and becomes phosphorylated on tyrosine, creating a motif recognized by the SH2 of GRB2 (33) ; this leads to formation of a SHC/GRB2/SOS complex thought to activate Ras (32) .
Because expression of pp60v-ff induces tyrosine phosphorylation of SHC and subsequent activation of Ras, activated pp60c-src in complex with MT might do the same. A potential candidate for SHC had been reported in MT immunoprecipitates, a 51-kDa protein of unknown identity (34) . Because phosphorylation at Tyr-250 was implicated in transformation, it was tempting to hypothesize that SHC might bind via its SH2 to this site. Our data confirm that SHC does bind to MT in an NPTY-dependent manner. Fig. 1 A and B) . A transformation-defective mutant MT with Asn-247 -+ Gly was also greatly reduced in SHC binding (data not shown). Two mutants were analyzed to test whether insertion of a wild-type NPTY downstream of the mutated motif, which was known to restore transformation competence, would also restore SHC binding to wild-type levels. This was, indeed, the case for 248-His-NPTY and 250-Phe-NPTY ( Fig. 1 A and B) . Finally, MT-NPTY, an NPTY insertion mutant in which a second NPTY was inserted into wild-type MT, also bound SHC ( Fig. 1 A and B) .
MATERIALS AND METHODS
Although necessary for optimal association with SHC, an intact NPXY in MT was not sufficient. NG59, a MT mutant defective in binding several associated proteins, including pp6OC-src, was defective in SHC binding ( Fig. 1 A andB) , even though its NPXY motif is intact. The defect of NG59 in associating with pp6W-src is consistent with the idea that phosphorylation of the NPXY on tyrosine is important for SHC binding.
Mutants at other critical sites in MT were tested to see if sequences besides those around residue 250 might be required for SHC binding. Tyr-315, the principal site oftyrosine phosphorylation, is part of the binding motif for PI 3-kinase. Its mutation to phenylalanine (315-Phe MT) renders the mutant middle defective in PI 3-kinase association (15) and in transformation (12, 13) . This MT mutant bound wild-type levels of SHC ( Fig. 1 A and B) . Similar results (data not shown) were obtained with d123 MT which deletes both Tyr-315 and Tyr-322 (11). Transfornation-defective d11015 (35) , which deletes a proline-rich sequence in MT, also bound SHC well (Fig. 1B) (Fig. 4) Whether the least abundant 66-kDa SHC form associates is unclear. Its level varies among cell lines (see Fig. 3 ) in a manner still to be explained.
In response to MT expression, SHC exhibits the hallmarks of activation: tyrosine phosphorylation and association with GRB2. Immunoblotting shows that the 46-and 52-kDa species are phosphorylated on tyrosine, and a large fraction of the 52-kDa form is shifted in mobility. SHC binds GRB2 when MT is expressed. Both the amount of SHC associated with GRB2 and the amount shifted in mobility are much greater than that in the MT complex. Because these effects require the ability of MT to complex with SHC, the MT complex appears to affect SHC in a "catalytic" manner. Alternatively, binding of SHC to MT may trigger a signal that results in widespread modification of SHC.
How does SHC binding relate to MT transformation? Signaling via p2lras is essential for MT (27, 28) . Because (54) . Two other activated receptor tyrosine kinases, EGF receptor and erbB-2, bind SHC (29, 31) . In both cases, the SHC SH2 domain was sufficient for association. For erbB-2, the binding site was localized to the C-terminal region containing the autophosphorylation sites, including two with the sequence NPEY (Table 1) . Simultaneous mutation of all five of these sites abolished SHC binding.
The MT complex resembles an activated growth factor receptor. SHC is the third SH2-containing protein known to complex with MT. Others probably remain to be discovered. In some MT complexes, PI 3-kinase and SHC appear to be on the same MT molecule. With growth factor receptors it has sometimes been difficult to see effects on mitogenesis by mutating any one of several SH2-binding sites. For instance, the phospholipase Cy-and SHC-binding sites in the nerve growth factor receptor are individually dispensable for nerve growth factor-mediated neurite outgrowth. MT-mediated transformation provides a sensitive system for studying signaling. Mutation of either the NPXY or the YMPM motif used for PI 3-kinase binding severely diminishes transformation function (12, 23) . The sensitivity of MT to mutation may result from the small number of activated MT molecules in a cell. Additional insight into transformation should come from the study of MT mutants like d11015, which are transformation defective but interact with all known host proteins (34, 38) 
